Published: 2017-01-23

Can Tc-99m labeled erythrocyte scintigraphy be an alternative non-invasive method to endometriosis diagnosis?

Fatih Demirel, Gokhan Koca, Koray Demirel, Huseyin Aydogmus, Aylin Akbulut, Murat Sadic, Hasan Ikbal Atilgan, Meliha Korkmaz, Bulent Gokmen


Background: Endometriosis is defined as the implantation of endometrial gland and stroma ectopically outside the uterus. Clinically, it is a hormone dependent benign disease accompanied by pelvic pain and infertility. The aim of this study was to demonstrate the activated implants with 99m-Tc labeled erythrocyte scintigraphy (99mTc-RBCs) in patients with recurrent endometriosis and compare the results with pelvic MRI results.

Methods: Patients who were diagnosed histopathologically as endometriosis either with operation and / or therapeutic laparascopy or laparotomy and, were included to present study. Thirty patients, who were diagnosed as recurrence by clinical, and laboratory terms and 10 healthy volunteer (control group) patients were included in the study. Between the second and fifth days of menstruation when the endometriotic lesions were highly activated, radionuclide imaging was performed by 99mTc-RBCs and compared with pelvic MRI findings.

Results: In 27 patients out of 30 patients (90%) pathological accumulation of radioactivity foci with 99mTc-RBCs were present. The focal pathological accumulation was significant in 26 patients and moderate in 1 patient. In 22 patients (81.5%) the increased radioactivity accumulation in radionuclide images was concordant with MRI images. Regarding the MRI as reference, the sensitivity of 99mTc-RBCs was determined as 96%, specificity 29%, positive predicitive value 81% and negative predictive value was 66%.

Conclusions: Imaging of endometriosis regions with 99m-Tc-RBCs can be an alternative diagnostic procedure for the patients with recurrent endometriosis.


Endometriosis, Magnetic resonance imaging, Tc-99m labeled erythrocyte scintigraphy

Full Text:



Falcone T, Lebovic DI. Clinical management of endometriosis. Obstet Gynecol. 2011;118:691-705.

Darrow SL, Vena JE, Batt RE, Zielezny MA, Michalek AM, Selman S. Menstrual cycle characteristics and the risk of endometriosis. Epidemiology. 2013;4:135-42.

Taylor RN. Endometriosis. In: Barbieri RL, Strauss JF, eds. Yen and Jaffe's Reproductive Endocrinology. 5th ed. Philadelphia, PA: Elsevier/Saunders. 2004:691-711.

Garry R, Clayton R, Hawe J. The effect of endometriosis and its radical laparoscopic excision on quality of life indicators. Br J Obstet Gynaecol. 2009;107:44-54.

Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362:2389-98.

Ling F. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group. Obstet Gynecol. 1999;93:51-8.

Moore J, Copley S, Morris J, Lindsell D, Golding S, Kennedy S. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis. Ultrasound Obstet Gynecol. 2002;20:630-4.

Patel MD, FeldsteinVA, Chen DC, Lipson SD, Filly RA. Endometriomas: diagnostic performans of US. Radiology. 1999;210:739-45.

Sugimura K, Okizuka H, Imaoka I, Kaji Y, Takahashi K, Kitao M, et al. Pelvic endometriosis: detection and diagnosis with chemical shift MR imaging. Radiology. 1993;188:435-8.

Moore J, Copley S, Morris J, Lindsell D, Golding S, Kennedy S. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis. Ultrasound Obstet Gynecol. 2002;20:630-4.

Barbieri RL, Niloff JM, Bast Jr RC, Schaetzi E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril. 1986;45:630-4.

Pittaway DE, Fayez JA. The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril. 1986;46:790-5.

Van Calster B, Timmerman D, Bourne T, Testa AC, Van Holsbeke C, Domali E, et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst. 2007;99:1706-14.

Chen FP, Soong YK, Lee N, Lo SK. The use of serum CA-125 as a marker for endometriosis in patients with dysmenorrhea for monitoring therapy and for recurrence of endometriosis. Acta Obstet Gynecol Scand. 1998;77:665-70.

Smith R, Copely DJ, Bolen FH. 99mTc-RBC scintigraphy: correlation of gastrointestinal bleeding rates with scintigraphic findings. AJR Am J Roentgenol. 1987;148:869-74.

Howarth DM. The role of nuclear medicine in the detection of acute gastrointestinal bleeding. Semin Nucl Med. 2006;36:133-46.

Sinzinger H, Rodrigues M. Chapter 8; Cellular labeling with Tc-99m chelates: Relevance of In vivo and In vitro viability testing. In: Zolle I, eds. Technetium-99m Pharmaceuticals: Preparation and Quality Control in Nuclear Medicine. 2nd ed. Berlin, Germany: Springer Berlin Heidelberg. 2007:103-7.

Cerci S, Cerci C, Balcı T, Komek H, Kılınç N. Abdominal wall endometriosis imaged with scintigraphy: report of a case. SDÜ Tıp Fak Derg. 2005;12:57-60.

Hascalik S, Celik O, Kekilli E, Elter K, Karakas HM, Aydin NE. Novel noninvasive detection method for endometriosis: research and development of scintigraphic survey on endometrial implants in rats. Fertilty and Sterility. 2008;90:209-13.

Kennedy SH, Soper NDW, Mojiminiyi OA, Shepstone BJ, Barlow DH. Immunoscintigraphy of ovarian endometriosis. A preliminary study. Br J Obstet Gynaecol. 1988;95:693-7.

Kennedy SH, Mojiminiyi OA, Soper NDW, Shepstone BJ, Barlow DH. Immunoscintigraphy of endometriosis. Br J Obstet Gynaecol. 1990;97:667-70.

Takahashi N, Yang DJ, Kurihara H, Borne A, Kohanim S, Oh CS, et al. Functional imaging of estrogen receptors with radiolabeled-GAP-EDL in rabbit endometriosis model. Acad Radiol. 2007;14:1050-7.

Chuang, Tzyy-Ling, Chun-Shuo Hsu, Yuh-Feng Wang. 131I SPECT/CT Demonstrated Ovarian Endometrioma. Clin Nuc Med. 2014;39:193-5.

Lin JH, Kok VC, Su JC. FDG-PET findings in an ovarian endometrioma, A case report. Ann Nucl Med Sci. 2008;21:109-13.

Derman AY, Sperling D, Merav A, Jain VR, Levin M, Jana S, et al. Endometrioma presenting as a cavitary lung mass with FDG uptake on PET-CT. J Thorac Imaging. 2007;22:172-5.

Jeffry L, Kerrou K, Camatte S, Metzger U, Lelièvre L, Talbot JN, et al. Endometriosis with FDG uptake on PET. Eur J Obstet Gynecol Reprod Biol. 2004;117:236-9.

Ge J, Zuo C, Guan Y, Zhang X. Increased 18F-FDG uptake of widespread endometriosis mimicking ovarian malignancy. Clin Nuc Med. 2015;40:186-8.

Fastrez M, Nogarède C, Tondeur M, Sirtaine N, Rozenberg S. Evaluation of 18 FDG PET-CT in the diagnosis of endometriosis: a prospective study. Reprod Sci. 2011;8:540-4.

Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2:CD009591.

Machado DE, Perini JA, Orlando MM, Santos-Oliveira R. Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis. Biomed Res Int. 2015;2015:751460.

Wang N, Hong S, Tan J, Ke P, Liang L, Fei H, et al. A red fluorescent nude mouse model of human endometriosis: advantages of a non-invasive imaging method. Eur J Obstet Gynecol Reprod Biol 2014;176:25-30.